While the drug may not be strong enough to treat colon cancer on its own, researchers believe it could enhance more aggressive therapies when used in combination.

Metformin and SGLT2 inhibitors are associated with similar rates of incident gout among patients with type 2 diabetes.

Researchers are exploring metformin, a common diabetes drug, as a potential aid in colon cancer treatment. Early studies ...

I f you pay attention to health news, you're unquestioningly aware that the rising rate of colon cancer among young people is ...

Metformin, one of the most used drugs on the planet, has the potential to improve old age ailments like physical disability, ...

What do chickens and people with a common reproductive disorder have in common? More than one might think—and a widely-used ...

Metformin is a go-to diabetes drug, and researchers are looking at whether it can be used as a cancer-fighting supplement, ...

For years, metformin has been the go-to first-line oral medication for patients newly diagnosed with type 2 diabetes. But ...

Type 2 diabetes is a long-term condition where the body struggles to manage sugar levels in the blood. Normally, doctors ...

Metformin is a well-known medicine that has been used to treat diabetes for more than 50 years. But now, researchers from the ...